Drug profile · INN
candicidin
VANOBID
candicidin (VANOBID) is a cell membrane inhibitor. Route of administration: vaginal. Current US regulatory status: approved.
FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — candicidin
- US status
- approved
- Class
- —
- Route
- VAGINAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
candicidin (VANOBID) is a cell membrane inhibitor. Route of administration: vaginal. Current US regulatory status: approved.
Key facts
INN candicidin
Brand VANOBID
Mechanism Cell membrane inhibitor
Target Cell membrane
Route VAGINAL
Formulation OINTMENT
Mechanism of action
Cell membrane inhibitor
Primary target: Cell membrane
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is candicidin?
candicidin (VANOBID) is a cell membrane inhibitor. Route of administration: vaginal. Current US regulatory status: approved.
What is the brand name for candicidin?
VANOBID is a marketed brand name for candicidin. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of candicidin?
candicidin has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.